The dynamic between the board of directors and executive leadership is often taken for granted, but plays a key role for the success of a biotechnology company. In a biotech start-up that fuses commercial and scientific functions, it is crucial for the decision-making process in the boardroom to be well-balanced; the executive team – especially … Continue reading Building a Strong Relationship with Management
The 8 Largest Biopharma M&A Deals of 2022 (Jan-Sep)
Despite 2022 being a relatively quiet year for M&A activity within the biopharma space, especially when compared to 2021, a number of prominent deals have taken place. Find out the 8 largest M&A deals of the year so far in order of the total amount. 8. Zogenix Acquired by: UCB Amount: USD 1.9bn After Zogenix’s … Continue reading The 8 Largest Biopharma M&A Deals of 2022 (Jan-Sep)
Current Trends in M&A Activity
In terms of M&A activity, 2022 is a rather quiet year so far compared to record-breaking year 2021 when private equity investments boomed. In this article, read about recent trends and an outlook on M&A deals in the life science industry. Upswing in biopharma M&As in Q2 2022 According to a report by J.P. Morgan, … Continue reading Current Trends in M&A Activity
Content Available For Free Thanks to our Partners
Biotechgate works in cooperation with over 30 partners located around the world. Our partners are a key source of information for our database, which is also disseminated into regional directories and portals covering that area’s life science activities and organizations. Thanks to these partnerships, a lot of information from Biotechgate is available free of charge. … Continue reading Content Available For Free Thanks to our Partners
How Can You Benefit From Biotechgate?
Biotechgate is a global life science database encompassing the pharma, biotech and medtech industries. But did you know that almost any kind of company within the life sciences can benefit from using Biotechgate? This article explains how different types of organizations can use the database effectively for their own BD&L activities. Big Pharma & Biotechs … Continue reading How Can You Benefit From Biotechgate?
Strong Partnership with Maryland Department of Commerce: Interview with Ulyana Desiderio
Biotechgate is in close partnership with the Maryland Department of Commerce. In an interview with Ulyana Desiderio, the Director of the Department’s Office of Life Science, she tells Biotechgate about her experience with the partnership and her work in the state’s life science ecosystem. Ulyana Desiderio is Director of the Office of Life Science at … Continue reading Strong Partnership with Maryland Department of Commerce: Interview with Ulyana Desiderio
South Korea Life Science Trend Analysis 2022
In 2021, biotech companies account for 44% of the life sciences companies in South Korea. More than half of South Korean biotechs are part of the therapeutics and diagnostics sector, of which 19% are publicly listed on the stock exchange. The total value of venture financing for South Korean life sciences companies dropped by around … Continue reading South Korea Life Science Trend Analysis 2022
The Current State of Therapeutics Financing: Trends in Public Market
Last month’s article on private equity therapeutics financing trends showed how biotech start-ups struggle to raise private equity investment this year, following the pandemic-driven life sciences boom. In this article, we will take a closer look at how recent challenges are reflected in the IPO market and outline public financing trends. In the wake of … Continue reading The Current State of Therapeutics Financing: Trends in Public Market
Finding Financial Information in Biotechgate
With over 1.3 million total entries, the Biotechgate Business Development and Investor databases serve as your primary source of information relating to the life science industry. This allows you to have access to data on organizations from start-ups right through to well-established multinationals and everything in between. Read on for an overview of the financial … Continue reading Finding Financial Information in Biotechgate
The 10 Largest Life Science IPOs (January – July, 2022)
IPOs serve as the lifeblood of the life science industry, allowing companies access to a vast source of capital that can fund their R&D activities and give previous investors a return on their initial financing. In 2022, there has been a noted contraction in the performance of life science IPOs which, in turn, has caused … Continue reading The 10 Largest Life Science IPOs (January – July, 2022)